AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30663595 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone prophylaxis
Number of subjects: 0
Study 30663595 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28375486 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy (nCT)
Number of subjects: 267
Study 28375486 — intervention group
Group type: COMPARATOR
Intervention: neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 267
Study 24923998 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush-based self-sampling device
Number of subjects: 30130
Study 24923998 — intervention group
Group type: COMPARATOR
Intervention: Lavage-based self-sampling device
Number of subjects: 30130
Study 23212275 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-DOTA-enhanced MRI
Number of subjects: 114
Study 23212275 — intervention group
Group type: COMPARATOR
Intervention: Control group (unenhanced MRI)
Number of subjects: 114
Study 21779745 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth/implant supported restoration
Number of subjects: 20
Study 21779745 — intervention group
Group type: COMPARATOR
Intervention: Implant only restoration
Number of subjects: 20
Study 19508580 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel applied to the wound twice a day for 60 days after removal of stitches
Number of subjects: 110
Study 19508580 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide cream
Number of subjects: 110
Study 16705264 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified LF‐ASD design
Number of subjects: 0
Study 16705264 — intervention group
Group type: COMPARATOR
Intervention: Previous LF‐ASD design
Number of subjects: 0
Study 14969652 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained audit/feedback program
Number of subjects: 22000
Study 14969652 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22000
Study 12490682 — intervention group
Group type: COMPARATOR
Intervention: High-dose dialysis
Number of subjects: 1846
Study 12490682 — intervention group
Group type: COMPARATOR
Intervention: High-flux dialyzer
Number of subjects: 1846
Study 12490682 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose dialysis
Number of subjects: 1846
Study 12490682 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flux dialyzer
Number of subjects: 1846
Study 12490682 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose and flux interventions
Number of subjects: 1846
Study 9813403 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postictal neuropsychological examination
Number of subjects: 17
Study 7616311 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation (20 mg/kg body wt) in young adult women
Number of subjects: 0
Study 7616311 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation (2.5 g/kg diet) in Sprague-Dawley rats
Number of subjects: 0
Study 7616311 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation (3 g/kg diet) in guinea pigs
Number of subjects: 0
Study 2092306 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention at 30 days postinfarction
Number of subjects: 51
Study 2092306 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study 2092306 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived beliefs of others
Number of subjects: 51
Study 2092306 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude
Number of subjects: 51
Study 2092306 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 51
Study 203998 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotropin (ACTH) 80 units intramuscularly daily
Number of subjects: 16
Study 203998 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone 400 mg infused intravenously over 24 hours
Number of subjects: 16
Study 7079035 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training (biweekly home visits for caregiving and sensorimotor exercises)
Number of subjects: 80
Study 7079035 — intervention group
Group type: EXPERIMENTAL
Intervention: Paid parent training as teacher's aides in the infant nursery
Number of subjects: 80
Study 7079035 — intervention group
Group type: COMPARATOR
Intervention: Control group (CETA-paid teacher's aides in a medical school infant nursery)
Number of subjects: 80
Study 31424503 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide withdrawal (n=95)
Number of subjects: 188
Study 31424503 — intervention group
Group type: COMPARATOR
Intervention: Furosemide maintenance (n=93)
Number of subjects: 188
Study 31424503 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 188
Study 29299602 — intervention group
Group type: EXPERIMENTAL
Intervention: UW‐IPASS standardized handoff curriculum
Number of subjects: 106
Study 29299602 — intervention group
Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 106
Study 27253202 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC intervention
Number of subjects: 605
Study 27253202 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 605
Study 25170902 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-based dietary advice report
Number of subjects: 138
Study 25170902 — intervention group
Group type: COMPARATOR
Intervention: General dietary advice report (Control)
Number of subjects: 138
Study 22500381 — intervention group
Group type: EXPERIMENTAL
Intervention: Erzhi Tiangui Granule combined with Western medicine
Number of subjects: 60
Study 22500381 — intervention group
Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 60
Study 20601398 — intervention group
Group type: EXPERIMENTAL
Intervention: Odstock dropped foot stimulator (ODFS)
Number of subjects: 64
Study 20601398 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy exercises
Number of subjects: 64
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intervention (one 30-minute call and a follow-up call)
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (five proactive calls)
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 4614
Study 18048633 — intervention group
Group type: COMPARATOR
Intervention: Brief intervention (one 15-minute call) without NRT
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (one 15-minute call) with NRT
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intervention (one 30-minute call and a follow-up call) without NRT
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intervention (one 30-minute call and a follow-up call) with NRT
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (five proactive calls) without NRT
Number of subjects: 4614
Study 18048633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (five proactive calls) with NRT
Number of subjects: 4614
Study 16225522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine suppositories (60 mg) applied 1 or 2 hours before biopsy
Number of subjects: 100
Study 16225522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine suppositories (60 mg) applied 1 hour before biopsy
Number of subjects: 100
Study 16225522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine gel (2% - 200 mg) applied 10 minutes before biopsy
Number of subjects: 100
Study 16225522 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 100
Study 11984384 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocols for data collection, training of data collectors, and data monitoring
Number of subjects: 0
Study 10432030 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine (30 microg each of gB2 and gD2, administered at months 0, 1, and 6)
Number of subjects: 2268
Study 10432030 — intervention group
Group type: COMPARATOR
Intervention: Placebo (citrate buffer vehicle)
Number of subjects: 2268
Study 10432030 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 2268
Study 10432030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2268
Study 8642806 — intervention group
Group type: COMPARATOR
Intervention: Rilmenidine (1 mg)
Number of subjects: 12
Study 8642806 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms)
Number of subjects: 12
Study 8642806 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (300 micrograms)
Number of subjects: 12
Study 8642806 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg)
Number of subjects: 12
Study 8642806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8642806 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilmenidine (2 mg)
Number of subjects: 12
Study 2155756 — intervention group
Group type: EXPERIMENTAL
Intervention: Otomize spray (neomycin/dexamethasone), administered 3 times daily for 10 days
Number of subjects: 187
Study 2155756 — intervention group
Group type: COMPARATOR
Intervention: Otosporin drops (neomycin/polymyxin B/hydrocortisone), administered 3 times daily for 10 days
Number of subjects: 187
Study 7435249 — intervention group
Group type: EXPERIMENTAL
Intervention: Melperone, 50 mg i.v.
Number of subjects: 26
Study 7435249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 30946197 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible locked intramedullary nail
Number of subjects: 72
Study 30946197 — intervention group
Group type: COMPARATOR
Intervention: Anatomically contoured locked plate
Number of subjects: 72
Study 28585351 — intervention group
Group type: EXPERIMENTAL
Intervention: Representation scaffolding during case processing
Number of subjects: 88
Study 28585351 — intervention group
Group type: COMPARATOR
Intervention: Control group (no scaffolding)
Number of subjects: 88
Study 26446479 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg kg(‐1) hr(‐1))
Number of subjects: 115
Study 26446479 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 115
Study 23704196 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A: 5‐fluorouracil, epirubicin, cyclophosphamide (FEC) + trastuzumab (H) + pertuzumab (P) ×3 → docetaxel (T) + H + P ×3
Number of subjects: 225
Study 23704196 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B: FEC ×3 → T + H + P ×3
Number of subjects: 225
Study 23704196 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm C: T + carboplatin + H (TCH) + P ×6
Number of subjects: 225
Study 21551394 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered care
Number of subjects: 509
Study 19157672 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide bleaching agent
Number of subjects: 30
Study 19157672 — intervention group
Group type: COMPARATOR
Intervention: Placebo agent
Number of subjects: 30
Study 17846068 — intervention group
Group type: EXPERIMENTAL
Intervention: Facio‐oral tract therapy for three weeks (15 sessions of 1 hour each)
Number of subjects: 10
Study 15142200 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 2 x 20 mg
Number of subjects: 13
Study 15142200 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 1 x 40 mg
Number of subjects: 13
Study 12575590 — intervention group
Group type: EXPERIMENTAL
Intervention: Huancongdan capsule (HCDC)
Number of subjects: 52
Study 12575590 — intervention group
Group type: COMPARATOR
Intervention: Naofukang (Control)
Number of subjects: 52
Study 9389288 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal glucocorticoid (beclomethasone dipropionate, 400 microg/day)
Number of subjects: 18
Study 9389288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8317687 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg acetylsalicylic acid (ASA) daily
Number of subjects: 40
Study 8317687 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg acetylsalicylic acid (ASA) daily
Number of subjects: 40
Study 8317687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosage groups (40 mg and 500 mg)
Number of subjects: 40
Study 3631421 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphocholinamin (nose drops)
Number of subjects: 12
Study 3631421 — intervention group
Group type: COMPARATOR
Intervention: Placebo (tap water nose drops)
Number of subjects: 12
Study 30640027 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise group (nine-week duration)
Number of subjects: 0
Study 30640027 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 0
Study 28797752 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive Spirometry (IS)
Number of subjects: 79
Study 28797752 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 79
Study 28797752 — intervention group
Group type: COMPARATOR
Intervention: Control (4L·min‐1 O2 via mask)
Number of subjects: 79
Study 26063325 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 10 mg per week (FA10)
Number of subjects: 100
Study 26063325 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 30 mg per week (FA30)
Number of subjects: 100
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum resistin levels in PAD patients
Number of subjects: 200
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum resistin levels in PAD subgroups
Number of subjects: 200
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: hsCRP levels in PAD patients
Number of subjects: 200
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: hsCRP levels among PAD subgroups
Number of subjects: 200
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ln-resistin levels correlation with ankle-brachial pressure index
Number of subjects: 200
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ln-resistin levels correlation with total cholesterol levels
Number of subjects: 200
Study 24067537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ln-resistin as a risk factor for PAD
Number of subjects: 200
Study 21572992 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline (0.25 ml of a 1:1,000 solution subcutaneously)
Number of subjects: 1007
Study 21572992 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg intravenously)
Number of subjects: 1007
Study 21572992 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg intravenously)
Number of subjects: 1007
Study 21572992 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline + Hydrocortisone
Number of subjects: 1007
Study 21572992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1007
Study 19191844 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic horse riding (10-week program)
Number of subjects: 99
Study 19191844 — intervention group
Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 99
Study 19191844 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic horse riding
Number of subjects: 99
Study 16790616 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 3 mg/kg
Number of subjects: 30
Study 16790616 — intervention group
Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 30
Study 12627741 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced intervention conditions
Number of subjects: 265
Study 12627741 — intervention group
Group type: COMPARATOR
Intervention: National Institute on Drug Abuse standard condition
Number of subjects: 265
Study 10696738 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent intra-arterial infusion of platinum drugs with radiation therapy (IAPRT)
Number of subjects: 33
Study 10696738 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 33
Study 8629920 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of a cane in the nondominant hand
Number of subjects: 16
Study 8629920 — intervention group
Group type: COMPARATOR
Intervention: No cane (control condition)
Number of subjects: 16
Study 8629920 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of a cane in the contralateral nondominant hand
Number of subjects: 16
Study 8629920 — intervention group
Group type: COMPARATOR
Intervention: No visual feedback
Number of subjects: 16
Study 8629920 — intervention group
Group type: COMPARATOR
Intervention: Inversion perturbation
Number of subjects: 16
Study 8629920 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane forces
Number of subjects: 16
Study 6388315 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole-trimethoprim (oral) for 14 days
Number of subjects: 25
Study 6388315 — intervention group
Group type: COMPARATOR
Intervention: Pentamidine (intramuscular) for 14 days
Number of subjects: 25
Study 30691177 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely randomized trees approach using precomputed features and data from the wrist sensor
Number of subjects: 0
Study 30691177 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional deep learning networks
Number of subjects: 0
Study 30691177 — intervention group
Group type: COMPARATOR
Intervention: Combination of two sensors (pocket and wrist)
Number of subjects: 0
Study 30259769 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine
Number of subjects: 20
Study 30259769 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of 1% lidocaine
Number of subjects: 20
Study 25774676 — intervention group
Group type: EXPERIMENTAL
Intervention: One hang-up visit
Number of subjects: 1811
Study 25774676 — intervention group
Group type: EXPERIMENTAL
Intervention: Two hang-up visits
Number of subjects: 1811
Study 25774676 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional visits)
Number of subjects: 1811
Study 25774676 — intervention group
Group type: EXPERIMENTAL
Intervention: All campaign nets hanging
Number of subjects: 1811
Study 23505991 — intervention group
Group type: EXPERIMENTAL
Intervention: Six 30-min phone consultation sessions
Number of subjects: 20
Study 23505991 — intervention group
Group type: COMPARATOR
Intervention: Workshop-only condition (no additional contact)
Number of subjects: 20
Study 21410922 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal school-based intervention in social-emotional learning and literacy development
Number of subjects: 1184
Study 19221594 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase change material (PCM) sodium acetate trihydrate, applied for 28-31 days for ulcers ≤2 cm and 50-55 days for ulcers >2 cm.
Number of subjects: 6
Study 19221594 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase change material (PCM) sodium acetate trihydrate, applied for thermotherapy.
Number of subjects: 6
Study 17584850 — intervention group
Group type: EXPERIMENTAL
Intervention: Bullard laryngoscope (Group BL)
Number of subjects: 62
Study 17584850 — intervention group
Group type: COMPARATOR
Intervention: Intubating Laryngeal Mask Airway (Group IL)
Number of subjects: 62
Study 17584850 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BL and ILMA)
Number of subjects: 62
Study 15052193 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphologically left ventricular reconditioning via pulmonary artery banding followed by an arterial switch operation and atrial reseptation
Number of subjects: 39
Study 15052193 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial switch operation and atrial reseptation
Number of subjects: 39
Study 15052193 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up
Number of subjects: 39
Study 15052193 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic evaluation
Number of subjects: 39
Study 15052193 — intervention group
Group type: EXPERIMENTAL
Intervention: Age greater than 12 years
Number of subjects: 39
Study 11300507 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 100 mg as a single oral dose
Number of subjects: 2
Study 11300507 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugwipe (immunochemical strip test)
Number of subjects: 2
Study 11300507 — intervention group
Group type: EXPERIMENTAL
Intervention: GC-MS for plasma and urine
Number of subjects: 2
Study 11300507 — intervention group
Group type: EXPERIMENTAL
Intervention: GC-MS for urine
Number of subjects: 2
Study 8185149 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive discharge planning protocol implemented by nurse specialists
Number of subjects: 276
Study 8185149 — intervention group
Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 276
Study 8185149 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard discharge planning)
Number of subjects: 276
Study 3070683 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin (400 mg) twice daily for 10 days
Number of subjects: 40
Study 3070683 — intervention group
Group type: COMPARATOR
Intervention: trimethoprim‐sulfamethoxazole (160‐800 mg) twice daily for 10 days
Number of subjects: 40
Study 30341453 — intervention group
Group type: EXPERIMENTAL
Intervention: SC abatacept 125 mg/week plus methotrexate (MTX)
Number of subjects: 0
Study 30341453 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 0
Study 30341453 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire-Disability Index
Number of subjects: 0
Study 28484308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus extra virgin olive oil (MeDiet+EVOO)
Number of subjects: 66
Study 28484308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus nuts (MeDiet+nuts)
Number of subjects: 66
Study 28484308 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 66
Study 26429851 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release niacin (ER-niacin)
Number of subjects: 38
Study 26429851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 23874021 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (20 mg/wk)
Number of subjects: 25000
Study 23874021 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-1β (IL-1β) inhibition (Canakinumab)
Number of subjects: 25000
Study 23874021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25000
Study 21931500 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-derived fulvic acid (CHD-FA)
Number of subjects: 36